Long-term results after transplantation of CD34+ selected (CellPro) versus unselected peripheral blood progenitor cells (PBPC) from related allogeneic donors-Reference-Cited by-同舟云学术

Long-term results after transplantation of CD34+ selected (CellPro) versus unselected peripheral blood progenitor cells (PBPC) from related allogeneic donors

Published:2010-03-09 Issue:12 Volume:136 Page:1921-1927
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Kopp Hans-Georg,Wirths Stefan,Faul Christoph,Bethge Wolfgang,Scheding Stefan,Brugger Wolfram,Kanz Lothar,Vogel Wichard

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-010-0851-6.pdf

Reference26 articles.

1. Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S, Felicini R, Falcinelli F, Velardi A, Ruggeri L, Aloisi T, Saab JP, Santucci A, Perruccio K, Martelli MP, Mecucci C, Reisner Y, Martelli MF (2005) Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 23:3447–3454

2. Bethge WA, Faul C, Bornhauser M, Stuhler G, Beelen DW, Lang P, Stelljes M, Vogel W, Hagele M, Handgretinger R, Kanz L (2008) Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. Blood Cells Mol Dis 40:13–19

3. Bornhauser M, Platzbecker U, Theuser C, Holig K, Ehninger G (2002) CD34 + -enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back. Br J Haematol 118:1095–1103

4. Butt NM, McGinnity N, Clark RE (2003) CD34 positive selection as prophylaxis against graft versus host disease in allogeneic peripheral blood stem cell transplantation. Leuk Lymphoma 44:1509–1513

5. Canals C, Martino R, Sureda A, Altes A, Briones J, Subira M, Ancin I, Martin-Henao G, Brunet S, Sierra J (2003) Strategies to reduce transplant-related mortality after allogeneic stem cell transplantation in elderly patients: comparison of reduced-intensity conditioning and unmanipulated peripheral blood stem cells vs a myeloablative regimen and CD34 + cell selection. Exp Hematol 31:1039–1043

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network geometry of evidence from randomised controlled trials addressing donor selection and source of haematopoietic progenitor cells used in allogeneic transplantation: a systematic scoping review;Transfusion Medicine;2018-01-30

2. Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation;Journal of Cancer Research and Clinical Oncology;2015-08-14

3. The road to purified hematopoietic stem cell transplants is paved with antibodies;Current Opinion in Immunology;2012-10